Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02093403
Title Decitabine and Selinexor in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ramiro Garzon

acute myeloid leukemia


Decitabine + Selinexor

Age Groups: adult
Covered Countries USA

No variant requirements are available.